News

02.12.2019

“The first steps are slow and then suddenly things start rolling”

“The first steps are slow and then suddenly things start rolling”

After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup raised 35 million CHF and will shortly complete the establishment of its new laboratory as the company progresses its products towards clinical development. With a lot of optimistic realism, Andreas takes stock.

mehr >
13.12.2019

Basel startup produces versatile lasers

Basel startup produces versatile lasers

Basel-based startup Menhir Photonics has developed an ultrafast laser that is precise, robust and can be used in a wide range of applications. The startup hopes to contribute to the development of new markets with its versatile laser.

mehr >
12.12.2019

Data Driven Healthcare – and Europe?

Data Driven Healthcare – and Europe?

The future of health is data driven. But are we ready for this to happen? This question was raised at our recent DayOne Expert Event. Answers were given by Dutch and Swiss leaders in digital health.

mehr >
22.10.2019

Switzerland Innovation Park Basel Area opens site in Jura

Switzerland Innovation Park Basel Area opens site in Jura

Switzerland Innovation Park Basel Area has opened its third location. The park is now represented in Jura alongside its locations in the Cantons of Basel-Landschaft and Basel-Stadt. This represents something of a milestone for the operators BaselArea.swiss.

mehr >
10.12.2019

Roche diabetes app replaces blood glucose meter

Roche diabetes app replaces blood glucose meter

Diabetes patients can use an app developed by Roche to determine their blood sugar levels on the basis of two photos taken on a cell phone camera. The Basel-based pharma group has now received the CE Mark for its app, paving the way for it to be marketed throughout Europe and in other countries around the world.

mehr >
09.12.2019

Pharmaceutical location Basel contributes to prosperity

Pharmaceutical location Basel contributes to prosperity

BAK Economics has presented on behalf of Interpharma the report The Importance of the Pharmaceutical Industry for Switzerland. The study reveals how much the pharmaceutical industry contributes to prosperity in Switzerland. Basel also stands out in an international comparison.

mehr >
26.09.2019

GRID boosts innovative power of Basel region

GRID boosts innovative power of Basel region

Work on the construction of the GRID complex for innovation and commerce has begun on the BaseLink site in Allschwil BL. By mid-2022, the Switzerland Innovation Park Basel Area will be operating from the new site as its anchor tenant.

mehr >
06.12.2019

BeiGene wins Scrip Award

BeiGene wins Scrip Award

The pharmaceutical company BeiGene has won a Scrip Award that recognizes contributions across the pharma sector to improving healthcare. BeiGene’s European headquarters is located in Basel.

mehr >
06.12.2019

Artidis raises close to CHF 9 million in seed funding

Artidis raises close to CHF 9 million in seed funding

Basel-based medtech company Artidis has raised CHF 8.8 million in seed funding in two rounds. A spin-off from the University of Basel, Artidis has developed a nanotechnology device for diagnosing cancer.

mehr >
26.09.2019

“The Switzerland Innovation Park Basel Area and the Jura are a match made in heaven”

“The Switzerland Innovation Park Basel Area and the Jura are a match made in heaven”

The Switzerland Innovation Park Basel Area will be opening its Jura site on 25 October. Claude-Henri Schaller, Director of the Office for the Economy and Labour and Vice President of Switzerland Innovation Park Basel Area AG, is convinced that the Innovation Park can make a major contribution to the diversification of industry in the Jura and will create stronger ties between industry and research.

mehr >
05.12.2019

Christian Müller is a leading global researcher

Christian Müller is a leading global researcher

The Basel heart specialist Christian Müller is one of the most frequently cited researchers in the world. The professor leads the Cardiovascular Research Institute Basel at the University Hospital Basel.

mehr >
02.12.2019

La meilleure façon de découvrir le Switzerland Innovation Park Basel Area

La meilleure façon de découvrir le Switzerland Innovation Park Basel Area

Le Co-Working est en plein essor dans le monde entier, y compris en Suisse. Depuis l'ouverture du Switzerland Innovation Park dans le canton du Jura, la perspective du Co-Working s'est enrichi d'un nouvel atout : depuis le mois d’octobre, le Parc de l'Innovation a ouvert ses portes à Courroux, près de Delémont. Son objectif est de renforcer l'innovation locale, simplifier les collaborations entre entreprises et créer un lieu vivant d'échange pour la recherche et la pratique. Le site du Jura par exemple, lancera des projets dans le domaine de la santé et du numérique au service de la santé. Les activités dans le domaine de la transformation industrielle ont également une place importante. En effet, les nombreux fournisseurs de l'industrie horlogère s'engagent à relever le défi de diversifier davantage leurs points forts et de se préparer ainsi pour l'avenir.

mehr >
19.09.2019

What we learned at this year’s DayOne Conference

What we learned at this year’s DayOne Conference

Twenty-two panellists and speakers, among them 3 patients and digital health futurist Maneesh Juneja, 30 project champions and their mentors, 40 volunteers and 450 participants and Arcondis as conference Partner  — this was the DayOne Conference which took place on September 9 at the FHNW in Muttenz.

mehr >
29.11.2019

Swiss TPH steps up fight against parasitic worm infections

Swiss TPH steps up fight against parasitic worm infections

The Basel based Swiss Tropical and Public Health Institute (Swiss TPH) is leading the newly founded HELP consortium, which brings together research institutes, pharmaceutical companies and other partners in an effort to develop new drugs for infections caused by parasitic worms.

mehr >
28.11.2019

Basel areas hold promise for investors

Basel areas hold promise for investors

Substantial efforts are underway in Basel to develop news areas and create space for people and companies. The efforts were welcomed by investors at the 17th Basler Investorengespräch.

mehr >
26.08.2019

"We make no compromises in creating the highest potential company"

Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond or CRISPR  Therapeutics. We talked to Alex Mayweg, partner at Versant Ventures in Basel, about the beauty of Versant Ventures discovery engine Ridgeline Therapeutics, translating science into successful drug development programs and the future of drug discovery.

mehr >
25.11.2019

BE4.0 – eine Plattform für die Industrie der Zukunft

BE4.0 – eine Plattform für die Industrie der Zukunft

4000 Besucher und 270 Aussteller: Die Industriemesse BE4.0, die am 19. und 20. November 2019 bereits zum 5. Mal stattfand, lockte ein grosses Publikum nach Mulhouse. Auch die Gewinner des Wettbewerbs i4Challenge 2019 präsentierten sich am Stand von BaselArea.swiss.

mehr >
25.11.2019

Novartis on the cusp of taking over The Medicines Company

Novartis on the cusp of taking over The Medicines Company

The Basel-based pharmaceutical company Novartis has come to an agreement with the management of the US firm The Medicines Company with regard to a takeover. The deal is expected to be closed at the start of 2020 for a total of 9.7 billion US dollars.

mehr >
11.06.2019

"I am amazed by the level of innovation in the Jura"

The Switzerland Innovation Park Basel Area already has two sites, in Allschwil and Basel, and will soon add a third in the Jura. It will be located on the Innodel campus in the municipality of Courroux, between Delémont and Courrendlin. Work is ongoing at the Jura site, which is set to officially open on 25 October.

mehr >
25.11.2019

Canton of Basel-Landschaft cuts corporate tax rates

Canton of Basel-Landschaft cuts corporate tax rates

Corporate tax rates in the canton of Basel-Landschaft will be cut from a maximum of 20.7 percent today to 13.45 percent in 2025. This has been stipulated by the proposed Tax Regulation 17, which was approved on Sunday.

mehr >
22.11.2019

Initiative for innovative companies in Basel-Landschaft

Initiative for innovative companies in Basel-Landschaft

A new initiative has been launched to support innovative SMEs and startups in the canton of Basel-Landschaft in an effort to make the region even more attractive and strengthen its ability to innovate. The initiative will offer both financial assistance and advisory services.

mehr >
06.05.2019

“Here at Bell, we combine handcraft and automation”

“Here at Bell, we combine handcraft and automation”

Over the space of 150 years, a butcher’s in Basel has grown into an international food company, with the Bell Food Group now employing more than 12,000 people in 15 countries. Markus Ettlin, Head of Industry 4.0/Automation at the Bell Food Group, provides an update on the company’s current Industry 4.0 projects, the limits of automation, and innovations in the food sector.

mehr >
20.11.2019

DayOne Accelerator finalizes participants

DayOne Accelerator finalizes participants

BaselArea.swiss manages the DayOne initiative, which is now organizing the second round of the DayOne Accelerator. The participants are Digital Health startups promoting the health of children and young people.

mehr >
20.11.2019

startup baselland supports company creation

startup baselland supports company creation

BaselArea.swiss is working with selected organizations and Standortförderung Baselland to support the foundation of companies in the canton of Basel-Landschaft. At the root of the partnerships is the initiative startup baselland.

mehr >
02.04.2019

“The Basel region is very advanced in healthcare innovation”

“The Basel region is very advanced in healthcare innovation”

A new master’s degree at the FHNW University of Applied Sciences and Arts Northwestern Switzerland aims to prepare the next generation of professionals in the life sciences industries: Students in “Medical Informatics” are trained to apply the latest technologies during projects for the medical and pharmaceutical industries. Professor Enkelejda Miho from the Institute for Medical and Analytical Technologies at FHNW is confident that the combination of life sciences, informatics and business brings forward a desired new profile of professionals.

mehr >
19.11.2019

Artidis joins world’s largest medical center

Artidis joins world’s largest medical center

The Basel-based startup Artidis is developing a medical device based on nanotechnology to help with cancer diagnoses. The spin-off from the University of Basel has now been successfully integrated in the Texas Medical Center and will therefore have access to the US market.

mehr >
15.11.2019

Basel professor receives Latsis Prize

Basel professor receives Latsis Prize

Randall Platt, a professor in the Department of Biosystems Science and Engineering at ETH Zurich in Basel, will receive the Latsis Prize for his outstanding work in the field of genome engineering.

mehr >
28.03.2019

33 recently arrived companies create hundreds of jobs

Basel and the Rhine - attractive for companies (img: Basel Tourismus)

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year – were persuaded to move to the Basel economic region. 16 companies arrived from Europe, nine of which came from Germany. BaselArea.swiss also supported six Swiss companies in the search for a suitable business location in the Basel region. Of the newly arrived companies, 19 operate in the life sciences and chemicals sectors.

mehr >
14.11.2019

Jura has plenty of greenfield sites

Jura has plenty of greenfield sites

The canton of Jura has more than 544 hectares of building land available, a study from the Federal Institute of Technology in Zurich (ETH) has found. Local authorities have now been presented with a detailed inventory.

mehr >
14.11.2019

Ist Ihre ICT bereit für die digitale Transformation?

Ist Ihre ICT bereit für die digitale Transformation?

Alle reden über Industrie 4.0, Data Analytics, Künstliche Intelligenz, AR, Blockchain, IoT etc. Derweil beschäftigen sich die ICT-Verantwortlichen mit Themen wie ERP Migrationen, Netzwerkmodernisierung oder Cloudüberführungen. Dabei stellt sich die Frage, ob die IT und Geschäftsprozesse wirklich so ausgelegt sind, dass der Schritt in die Digitalisierung gelingen kann. Am Technology Circle (TC) vom 22. Oktober im Business Park Oberbaselbiet sollte aufgezeigt werden, unter welchen Voraussetzungen Digitalisierung und digitale Transformation erfolgreich umgesetzt werden können. Die Veranstaltung wurde von BaselArea.swiss organisiert.

mehr >
05.03.2019

Healthcare innovations gain traction with the DayOne Accelerator

Healthcare innovations gain traction with the DayOne Accelerator

Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from Advancience are examples of how far conviction can get you.

mehr >
13.11.2019

Qnami raises 2.6 million Swiss francs

Qnami raises 2.6 million Swiss francs

A Basel startup has closed a successful seed round totaling 2.6 million Swiss francs from several investors. Qnami will use the funds to support the market entry of its quantum microscope for the analysis of magnetic materials at the nanoscale.

mehr >
12.11.2019

Vaximm is using AI to develop cancer vaccines

Vaximm is using AI to develop cancer vaccines

Basel-based biotech company Vaximm has agreed a collaboration with IT company NEC. Vaximm wants to develop personalized cancer vaccines using NEC’s artificial intelligence (AI)-based prediction system.

mehr >
05.02.2019

“We are a small company with a big portfolio”

“We are a small company with a big portfolio”

After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s biggest biotech, the company and its late-stage pipeline were acquired by Johnson&Johnson in 2017. With Actelion’s discovery- and early-stage R&D assets, the couple formed Idorsia, with the vision to build one of Europe’s leading biopharmaceutical companies

mehr >
11.11.2019

Basel startup Nutrix beats 900 startups

Basel startup Nutrix beats 900 startups

The Basel startup Nutrix has won a competition at the Web Summit with its business concept. It has developed a nanosensor that measures glucose levels in users’ saliva to prevent diabetes. Nutrix is supported by the Venture Mentoring program of BaselArea.swiss and has been shortlisted for the DayOne Accelerator.

mehr >
08.11.2019

Genedata digitalizing processes for Boehringer Ingelheim

Genedata digitalizing processes for Boehringer Ingelheim

The Basel-based IT company Genedata, which specializes in supplying software solutions to the biopharmaceutical industry, has expanded its partnership with Boehringer Ingelheim. Genedata will now be digitalizing and automating cell line development processes for the pharma group.

mehr >
08.01.2019

"It doesn't always have to stay the same"

Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.

mehr >
07.11.2019

Basel-Stadt offers free open data

Basel-Stadt offers free open data

The canton of Basel-Stadt has established a new data platform. At the click of a button, users can access data on car park occupancy or air quality.

mehr >
05.11.2019

The winners of the i4Challenge introduce themselves

The winners of the i4Challenge introduce themselves

Six companies won the i4Challenge: Arviem, Crevoisier, LCB Sarl, Qiio, Unitelabs and United Planet. We asked the winners to introduce themselves.

mehr >
03.12.2018

“Momentum for blockchain in healthcare is growing in Basel”

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)